Alvimopan is a peripherally acting mu-opioid receptor antagonist (PAMORA) used primarily to accelerate gastrointestinal recovery following bowel resection surgery with primary anastomosis. Chemically, it is a derivative of the opioid antagonist naloxone. Alvimopan works by selectively blocking the mu-opioid receptors in the gastrointestinal tract, thereby reducing the inhibitory effects of opioids on gut motility and secretion. This leads to faster restoration of bowel function, decreased postoperative ileus (delayed bowel function), and shorter hospital stays. Alvimopan is typically administered orally in the immediate preoperative period and continued for a limited duration postoperatively. It is contraindicated in patients who have received therapeutic doses of opioids for more than 7 consecutive days prior to surgery or in those with a known or suspected gastrointestinal obstruction or perforation. Buy high quality Alvimopan from Chemicea Pharmaceuticals. Chemicea Pharmaceuticals is one of the leading manufacturer and exporter of Alvimopan.
Alvimopan
CAT. No.
CP-A127000
CAS. No.
156053-89-3
Mol. F.
C25H32N2O4
Mol. Wt.
424.54
Stock Status
Custom Synthesis
Rel. Cas No
1007347-23-0 (HCl salt) ; 934161-30-5 (Na salt) ; 170098-38-1 (Dihydrate)
Chemical Name:((S)-2-Benzyl-3-((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)propanoyl)glycine
Request for Quotation : Alvimopan
Thank You
We have received your request successfully. Thank you for your interest in our product line. To
provide you with a Quotation, Our Sales team will contact you shortly.
Chemicea Pharmaceuticals Pvt. Ltd.
Thank You
You will receive blog content, featuring scientific research and exclusive promotions.